Medigene AG (XTER:MDG1) EV-to-Revenue : 3.59 (As of May. 24, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Medigene AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medigene AG's enterprise value is €21.65 Mil. Medigene AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €6.03 Mil. Therefore, Medigene AG's EV-to-Revenue for today is 3.59.

The historical rank and industry rank for Medigene AG's EV-to-Revenue or its related term are showing as below:

XTER:MDG1' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.18 Med: 6.95 Max: 37.94
Current: 3.59

During the past 13 years, the highest EV-to-Revenue of Medigene AG was 37.94. The lowest was 0.18. And the median was 6.95.

XTER:MDG1's EV-to-Revenue is ranked better than
69.56% of 1038 companies
in the Biotechnology industry
Industry Median: 8.22 vs XTER:MDG1: 3.59

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), Medigene AG's stock price is €1.20. Medigene AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.23. Therefore, Medigene AG's PS Ratio for today is 5.15.

Medigene AG EV-to-Revenue Historical Data

The historical data trend for Medigene AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG EV-to-Revenue Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

4.66

7.70

4.97

0.64

3.93

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															4.97	15.60	0.64	-	3.93

Competitive Comparison of Medigene AG's EV-to-Revenue

For the Biotechnology subindustry, Medigene AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medigene AG's EV-to-Revenue falls into.

Medigene AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medigene AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	21.646	/	6.034
	=	3.59

Medigene AG's current Enterprise Value is €21.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medigene AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €6.03 Mil.

Medigene AG (XTER:MDG1) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medigene AG's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.20	/	0.233
	=	5.15

Medigene AG's share price for today is €1.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.23.

Medigene AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medigene AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (XTER:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (XTER:MDG1) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Austria

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (XTER:MDG1) Headlines

No Headlines